Mifamurtide (Mepact)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 12:16, 23 September 2023 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mechanism of action

Fully synthetic derivative of muramyl dipeptide (MDP)

Diseases for which it is used

History of changes in EMA indication

  • 2009-03: Initial marketing authorisation

Also known as

  • Brand name: Mepact
Retrieved from "https://hemonc.org/w/index.php?title=Mifamurtide_(Mepact)&oldid=78105"